In this review, we focus on the important newly recognized appreciation
for the paradoxical increase in stroke and TIA as a result of intervention meant
to treat atrial fibrillation (AF) with the hope of decreasing stroke risk in the
long term. The impact of silent cerebral lesions recently appreciated as a
potentially major limitation and risk with AF ablation is explained. We
categorize our present understanding of how we can minimize risk and provide a
platform for what will undoubtedly be newer study, changes in the way procedures
are done today, and possibly vascular-based stroke-reduction strategies.